{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:57:08Z","timestamp":1791889028603,"version":"4.3.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"bioM\u00e9rieux"},{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon-2020"},{"name":"Marie Sk\u0142odowska-Curie Innovative Training Networks"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Critical illness such as sepsis is a life-threatening syndrome defined as a dysregulated host response to infection and is characterized by patients exhibiting impaired immune response. In the field of diagnosis, a gap still remains in identifying the immune profile of critically ill patients in the intensive care unit (ICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A new multiplex immune profiling panel (IPP) prototype was assessed for its ability to semiquantify messenger RNA immune-related markers directly from blood, using the FilmArray System, in less than an hour. Samples from 30 healthy volunteers were used for the technical assessment of the IPP tool. Then the tool was clinically assessed using samples from 10 healthy volunteers and 20 septic shock patients stratified using human leukocyte antigen\u2013DR expression on monocytes (mHLA-DR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The IPP prototype consists of 16 biomarkers that target the immune response. The majority of the assays had a linear expression with different RNA inputs and a coefficient of determination (R2) &amp;gt; 0.8. Results from the IPP pouch were comparable to standard quantitative polymerase chain reaction and the assays were within the limits of agreement in Bland\u2013Altman analysis. Quantification cycle values of the target genes were normalized against reference genes and confirmed to account for the different cell count and technical variability. The clinical assessment of the IPP markers demonstrated various gene modulations that could distinctly differentiate 3 profiles: healthy volunteers, intermediate mHLA-DR septic shock patients, and low mHLA-DR septic shock patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of IPP showed great potential for the development of a fully automated, rapid, and easy-to-use immune profiling tool. The IPP tool may be used in the future to stratify critically ill patients in the ICU according to their immune status. Such stratification will enable personalized management of patients and guide treatments to avoid secondary infections and lower mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa248","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T15:09:39Z","timestamp":1588777779000},"page":"S84-S95","source":"Crossref","is-referenced-by-count":24,"title":["Immune Profiling Panel: A Proof-of-Concept Study of a New Multiplex Molecular Tool to Assess the Immune Status of Critically Ill Patients"],"prefix":"10.1093","volume":"222","author":[{"given":"Dina M","family":"Tawfik","sequence":"first","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Vachot","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Bocquet","sequence":"additional","affiliation":[{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Anaesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Immunology Laboratory, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Blein","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L","family":"Montgomery","sequence":"additional","affiliation":[{"name":"BioFire Diagnostics LLC, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C","family":"Hemmert","sequence":"additional","affiliation":[{"name":"BioFire Diagnostics LLC, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Pachot","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Moucadel","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Yugueros-Marcos","sequence":"additional","affiliation":[{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brengel-Pesce","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mallet","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3821-9337","authenticated-orcid":false,"given":"Julien","family":"Textoris","sequence":"additional","affiliation":[{"name":"EA7426 \u201cPathophysiology of Injury-Induced Immunosuppression,\u201d PI3, Universit\u00e9 Claude Bernard Lyon-1 Hospices Civils de Lyon, bioM\u00e9rieux, Lyon, France"},{"name":"Open Innovation and Partnerships, bioM\u00e9rieux, Lyon, France"},{"name":"Anaesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"2020072103265054300_CIT0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2020072103265054300_CIT0002","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2020072103265054300_CIT0003","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"2020072103265054300_CIT0004","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13054-017-1910-z","article-title":"The coming era of precision medicine for intensive care","volume":"21","author":"Vincent","year":"2017","journal-title":"Crit Care"},{"key":"2020072103265054300_CIT0005","doi-asserted-by":"crossref","first-page":"17296","DOI":"10.1038\/s41598-018-35932-0","article-title":"Proof of concept study of mass cytometry in septic shock patients reveals novel immune alterations","volume":"8","author":"Gossez","year":"2018","journal-title":"Sci Rep"},{"key":"2020072103265054300_CIT0006","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00134-018-5247-0","article-title":"Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study","volume":"44","author":"Conway Morris","year":"2018","journal-title":"Intensive Care Med"},{"key":"2020072103265054300_CIT0007","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc8872","article-title":"Sepsis biomarkers: a review","volume":"14","author":"Pierrakos","year":"2010","journal-title":"Crit Care"},{"key":"2020072103265054300_CIT0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/CMR.00016-12","article-title":"New approaches to sepsis: molecular diagnostics and biomarkers","volume":"25","author":"Reinhart","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2020072103265054300_CIT0009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.imlet.2004.07.009","article-title":"The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration","volume":"95","author":"Monneret","year":"2004","journal-title":"Immunol Lett"},{"key":"2020072103265054300_CIT0010","first-page":"2746","article-title":"Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction","volume":"37","author":"Lukaszewicz","year":"2009","journal-title":"Crit Care Med"},{"key":"2020072103265054300_CIT0011","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1128\/IAI.01213-09","article-title":"Characterization and modulation of the immunosuppressive phase of sepsis","volume":"78","author":"Muenzer","year":"2010","journal-title":"Infect Immun"},{"key":"2020072103265054300_CIT0012","doi-asserted-by":"crossref","first-page":"e98960","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"key":"2020072103265054300_CIT0013","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2020072103265054300_CIT0014","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3389\/fimmu.2018.01926","article-title":"Precision immunotherapy for sepsis","volume":"9","author":"Peters van Ton","year":"2018","journal-title":"Front Immunol"},{"key":"2020072103265054300_CIT0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020072103265054300_CIT0016","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: restoration by IFN-gamma treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat Med"},{"key":"2020072103265054300_CIT0017","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"2020072103265054300_CIT0018","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"key":"2020072103265054300_CIT0019","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3389\/fimmu.2018.02367","article-title":"Immune functional assays, from custom to standardized tests for precision medicine","volume":"9","author":"Albert-Vega","year":"2018","journal-title":"Front Immunol"},{"key":"2020072103265054300_CIT0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1751143718765407","article-title":"Immune therapy in sepsis: are we ready to try again?","volume":"19","author":"Davies","year":"2018","journal-title":"J Intensive Care Soc"},{"key":"2020072103265054300_CIT0021","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2020072103265054300_CIT0022","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2020072103265054300_CIT0023","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41467-018-03078-2","article-title":"A community approach to mortality prediction in sepsis via gene expression analysis","volume":"9","author":"Sweeney","year":"2018","journal-title":"Nat Commun"},{"key":"2020072103265054300_CIT0024","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcrc.2018.10.028","article-title":"Validation of diagnostic gene sets to identify critically ill patients with sepsis","volume":"49","author":"Maslove","year":"2019","journal-title":"J Crit Care"},{"key":"2020072103265054300_CIT0025","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cmi.2018.03.011","article-title":"Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"24","author":"Rello","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2020072103265054300_CIT0026","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14737159.2018.1493378","article-title":"The host response as a tool for infectious disease diagnosis and management","volume":"18","author":"Lydon","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"2020072103265054300_CIT0027","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/cid\/ciw494","article-title":"Multiplexed molecular diagnostics for respiratory, gastrointestinal, and central nervous system infections","volume":"63","author":"Hanson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020072103265054300_CIT0028","doi-asserted-by":"crossref","first-page":"e26047","DOI":"10.1371\/journal.pone.0026047","article-title":"FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection","volume":"6","author":"Poritz","year":"2011","journal-title":"PLoS One"},{"key":"2020072103265054300_CIT0029","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","article-title":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock","volume":"32","author":"Monneret","year":"2006","journal-title":"Intensive Care Med"},{"key":"2020072103265054300_CIT0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.diagmicrobio.2012.08.003","article-title":"Comparison of FilmArray Respiratory Panel and laboratory-developed real-time reverse transcription-polymerase chain reaction assays for respiratory virus detection","volume":"74","author":"Renaud","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020072103265054300_CIT0031","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/591859","article-title":"Nosocomial infection after septic shock among intensive care unit patients","volume":"29","author":"Landelle","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020072103265054300_CIT0032","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-010-1962-x","article-title":"Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock","volume":"36","author":"Landelle","year":"2010","journal-title":"Intensive Care Med"},{"key":"2020072103265054300_CIT0033","article-title":"Rapid discrimination of viral and bacterial infections by host transcriptomic analysis using FilmArray system [abstract 3472]","author":"Montgomery","year":"2017","journal-title":"American"},{"key":"2020072103265054300_CIT0034","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/JCM.00730-16","article-title":"Multicenter evaluation of Biofire FilmArray meningitis\/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens","volume":"54","author":"Leber","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2020072103265054300_CIT0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"2020072103265054300_CIT0036","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tifs.2014.03.008","article-title":"Guidelines for validation of qualitative real-time PCR methods","volume":"37","author":"Broeders","year":"2014","journal-title":"Trends Food Sci Technol"},{"key":"2020072103265054300_CIT0037","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2020072103265054300_CIT0038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13054-016-1583-z","article-title":"Towards precision medicine for sepsis patients","volume":"21","author":"Pickkers","year":"2017","journal-title":"Crit Care"},{"key":"2020072103265054300_CIT0039","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.coi.2013.05.006","article-title":"Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies","volume":"25","author":"Venet","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"2020072103265054300_CIT0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00134-017-4805-1","article-title":"Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study","volume":"43","author":"Peronnet","year":"2017","journal-title":"Intensive Care Med"},{"key":"2020072103265054300_CIT0041","doi-asserted-by":"crossref","first-page":"15949","DOI":"10.1038\/ncomms15949","article-title":"A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification","volume":"8","author":"Hassan","year":"2017","journal-title":"Nat Commun"},{"key":"2020072103265054300_CIT0042","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00134-019-05909-2","article-title":"Immunity check should be performed for all patients with septic shock? Yes","volume":"46","author":"Textoris","year":"2020","journal-title":"Intensive Care Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_2\/S84\/33515954\/jiaa248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_2\/S84\/33515954\/jiaa248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T03:31:12Z","timestamp":1595302272000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/Supplement_2\/S84\/5874162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":42,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2020,7,21]]},"published-print":{"date-parts":[[2020,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa248","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/636522","asserted-by":"object"}]},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,15]]},"published":{"date-parts":[[2020,7,21]]}}}